Novel technology
The cosmetic ingredients distributor has appointed Azelis as its exclusive distributor in China. Through this arrangement, Azelis will present Tagra Biotechnologies’ range of RND microencapsulated actives and pigments in the leading skin care, decorative cosmetics, hair care and fragrance markets for personal care usage.
Along with cosmetics ingredients, Tagra Biotechnologies is also known for its Release on Demand (RND) Microencapsulation Technology, a patented method that strives to provide a controlled and efficient release for non-water soluble ingredients.
It applies this technology to its range of encapsulated actives and pigments including anti-ageing, anti-acne, brightening, pigment, moisturising and sun care ingredients.
Tagra Biotechnologies’ encapsulated ingredients include actives, vitamins, essential oils, flavonoids, silicones, pigments and sunscreens, that can be utilised in a variety of formulations for personal care applications.
Strengthening its presence
The duo’s latest partnership adds to their existing agreements for speciality chemical sales in Australia, New Zealand, Europe and Canada, and is set to push Azelis’ brand awareness in the APAC region.
Lito Ickowicz, Director Business Development, Tagra Biotechnologies commented that the move is set to strengthen their existing alliance: “Azelis is a long-trusted partner of Tagra, so the decision to further expand into China with them came only natural to us...we aim to offer customers high-quality technical service and innovative application insights.”
“We both have a high focus on innovation and Tagra’s cutting-edge ingredients represent a perfect fit for both our portfolio and our strategy to focus on creating value for our customers in Asia Pacific,” stated Laurent Nataf, CEO & President Asia Pacific, Azelis.
Strategic alliance
This year, Azelis won the Personal Care Cosmetics Fountain Innovation Award 2017 at PCHi exhibition in Guangzhou, marking three years in a row for the chemicals company.
By combining its focus on high-quality and Tagra Biotechnologies' innovation in development and manufacturing, together, they hope to make significant inroads in the Chinese personal care market.
First stop Australia and New Zeal, now China.
The agreement, which is effective immediately, follows Azelis’ acquisition of manufacturing and formulations name, Chemcolor in July 2017.
As that agreement marked a move towards increasing its presence in Australia and New Zealand, the company’s latest agreement with its existing partner aims to raise its profile in China and create growth in the Asia-Pacific market.